- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 57 | 0.0 | 0.0 | -0.47 | 25.4 | -9.3 | -0.46 | 23.33 | 37.84 | -1.45 | -47.96 | 22.87 | 0.62 | 44.19 | 29.17 | 56.47 | -3.83 | 38.24 | -42.69 | 47.02 | 52.55 | -45.06 | 47.78 | 16.07 | -0.27 | 22.86 | 37.21 | -0.27 | 25.0 | -8.0 | -45.06 | 47.78 | 16.07 | -45.06 | 47.78 | 16.07 | 18.84 | -27.30 | 22.70 |
| 24Q2 (19) | 57 | 0.0 | 0.0 | -0.63 | -80.0 | 21.25 | -0.60 | 22.08 | 42.31 | -0.98 | -180.0 | 32.41 | 0.43 | -6.52 | -20.37 | 58.72 | 31.69 | 919.44 | -80.57 | 18.43 | 26.81 | -86.29 | -84.03 | 0.71 | -0.35 | 22.22 | 41.67 | -0.36 | -80.0 | 21.74 | -86.29 | -84.03 | 0.71 | -86.29 | -84.03 | 0.71 | -11.44 | -7.33 | 9.01 |
| 24Q1 (18) | 57 | 0.0 | 23.91 | -0.35 | 65.35 | 56.79 | -0.77 | -4.05 | -28.33 | -0.35 | 87.89 | 56.79 | 0.46 | -16.36 | -32.35 | 44.59 | 258.85 | 50.74 | -98.77 | 40.42 | -90.79 | -46.89 | 56.62 | 16.0 | -0.45 | 50.55 | -28.57 | -0.2 | 65.52 | 45.95 | -46.89 | 76.03 | 16.0 | -46.89 | 56.62 | 16.0 | -0.89 | -34.77 | -2.02 |
| 23Q4 (17) | 57 | 0.0 | 23.91 | -1.01 | -134.88 | 11.4 | -0.74 | 0.0 | 6.33 | -2.89 | -53.72 | -159.96 | 0.55 | 14.58 | -35.29 | -28.07 | -168.71 | -723.78 | -165.79 | -84.27 | -156.96 | -108.08 | -101.3 | -81.68 | -0.91 | -111.63 | -65.45 | -0.58 | -132.0 | -9.43 | -195.62 | -264.35 | -165.82 | -108.08 | -101.3 | -81.68 | 1.74 | -44.31 | 14.43 |
| 23Q3 (16) | 57 | 0.0 | 23.91 | -0.43 | 46.25 | -153.75 | -0.74 | 28.85 | -384.62 | -1.88 | -29.66 | -131.54 | 0.48 | -11.11 | -54.72 | 40.85 | 609.2 | -45.15 | -89.97 | 18.27 | -494.61 | -53.69 | 38.22 | -252.83 | -0.43 | 28.33 | -279.17 | -0.25 | 45.65 | -167.57 | -53.69 | 38.22 | -224.17 | -53.69 | 38.22 | -252.83 | -15.85 | 23.74 | -22.24 |
| 23Q2 (15) | 57 | 23.91 | 35.71 | -0.80 | 1.23 | -124.39 | -1.04 | -73.33 | -146.02 | -1.45 | -79.01 | -125.57 | 0.54 | -20.59 | -83.28 | 5.76 | -80.53 | -91.89 | -110.08 | -112.63 | -325.39 | -86.91 | -55.7 | -311.61 | -0.6 | -71.43 | -137.97 | -0.46 | -24.32 | -133.58 | -86.91 | -55.7 | -269.05 | -86.91 | -55.7 | -311.61 | -20.30 | 15.09 | -24.64 |
| 23Q1 (14) | 46 | 0.0 | 9.52 | -0.81 | 28.95 | -133.89 | -0.60 | 24.05 | -137.5 | -0.81 | -116.8 | -133.89 | 0.68 | -20.0 | -71.19 | 29.58 | 557.33 | -60.8 | -51.77 | 19.76 | -206.7 | -55.82 | 6.17 | -233.89 | -0.35 | 36.36 | -130.7 | -0.37 | 30.19 | -137.0 | -55.82 | 24.15 | -206.79 | -55.82 | 6.17 | -233.89 | -19.91 | -106.78 | -189.90 |
| 22Q4 (13) | 46 | 0.0 | 9.52 | -1.14 | -242.5 | -175.0 | -0.79 | -403.85 | -169.3 | 4.82 | -19.13 | -46.5 | 0.85 | -19.81 | -61.71 | 4.50 | -93.96 | -93.55 | -64.52 | -382.98 | -266.2 | -59.49 | -269.34 | -321.73 | -0.55 | -329.17 | -163.95 | -0.53 | -243.24 | -182.81 | -73.59 | -270.19 | -292.19 | -59.49 | -269.34 | -321.73 | -43.50 | -159.06 | -246.18 |
| 22Q3 (12) | 46 | 9.52 | 9.52 | 0.80 | -75.61 | -69.7 | 0.26 | -88.5 | -86.73 | 5.96 | 5.11 | -20.43 | 1.06 | -67.18 | -62.41 | 74.48 | 4.87 | 7.72 | 22.80 | -53.32 | -53.68 | 35.13 | -14.46 | -9.44 | 0.24 | -84.81 | -82.73 | 0.37 | -72.99 | -66.36 | 43.24 | -15.89 | -11.08 | 35.13 | -14.46 | -9.44 | -15.16 | -19.18 | -23.62 |
| 22Q2 (11) | 42 | 0.0 | 2.44 | 3.28 | 37.24 | 21.48 | 2.26 | 41.25 | 7.11 | 5.67 | 137.24 | 13.4 | 3.23 | 36.86 | 17.03 | 71.02 | -5.88 | -8.83 | 48.84 | 0.66 | -3.46 | 41.07 | -1.49 | 4.56 | 1.58 | 38.6 | 13.67 | 1.37 | 37.0 | 24.55 | 51.41 | -1.65 | 9.24 | 41.07 | -1.49 | 4.56 | 21.59 | 47.24 | 40.80 |
| 22Q1 (10) | 42 | 0.0 | 2.44 | 2.39 | 57.24 | 4.37 | 1.60 | 40.35 | -1.84 | 2.39 | -73.47 | 4.37 | 2.36 | 6.31 | 1.29 | 75.46 | 8.2 | -3.86 | 48.52 | 24.99 | -4.32 | 41.69 | 55.39 | 3.94 | 1.14 | 32.56 | -3.39 | 1.0 | 56.25 | 7.53 | 52.27 | 36.51 | 3.4 | 41.69 | 55.39 | 3.94 | -7.49 | 7.41 | -0.75 |
| 21Q4 (9) | 42 | 0.0 | 2.44 | 1.52 | -42.42 | -32.14 | 1.14 | -41.84 | -37.02 | 9.01 | 20.29 | 42.11 | 2.22 | -21.28 | -22.11 | 69.74 | 0.87 | 2.82 | 38.82 | -21.13 | -10.24 | 26.83 | -30.83 | -6.19 | 0.86 | -38.13 | -30.08 | 0.64 | -41.82 | -29.67 | 38.29 | -21.26 | -2.0 | 26.83 | -30.83 | -6.19 | -9.55 | -22.32 | -24.48 |
| 21Q3 (8) | 42 | 2.44 | 2.44 | 2.64 | -2.22 | 57.14 | 1.96 | -7.11 | 56.8 | 7.49 | 49.8 | 82.68 | 2.82 | 2.17 | 51.61 | 69.14 | -11.25 | -13.17 | 49.22 | -2.71 | 10.48 | 38.79 | -1.25 | 4.19 | 1.39 | 0.0 | 67.47 | 1.1 | 0.0 | 61.76 | 48.63 | 3.34 | 12.8 | 38.79 | -1.25 | 4.19 | 10.31 | 7.84 | 11.17 |
| 21Q2 (7) | 41 | 0.0 | 0.0 | 2.70 | 17.9 | 29.19 | 2.11 | 29.45 | 33.54 | 5.00 | 118.34 | 107.47 | 2.76 | 18.45 | 7.39 | 77.90 | -0.75 | 1.58 | 50.59 | -0.24 | 3.77 | 39.28 | -2.07 | 9.97 | 1.39 | 17.8 | 11.2 | 1.1 | 18.28 | 29.41 | 47.06 | -6.9 | 0.15 | 39.28 | -2.07 | 9.97 | 0.10 | 10.06 | 9.75 |
| 21Q1 (6) | 41 | 0.0 | 0.0 | 2.29 | 2.23 | 593.94 | 1.63 | -9.94 | 805.56 | 2.29 | -63.88 | 593.94 | 2.33 | -18.25 | 80.62 | 78.49 | 15.72 | 4.49 | 50.71 | 17.25 | 173.07 | 40.11 | 40.24 | 144.57 | 1.18 | -4.07 | 391.67 | 0.93 | 2.2 | 615.38 | 50.55 | 29.38 | 145.15 | 40.11 | 40.24 | 144.57 | 17.49 | 17.78 | 17.43 |
| 20Q4 (5) | 41 | 0.0 | 5.13 | 2.24 | 33.33 | 474.36 | 1.81 | 44.8 | 465.62 | 6.34 | 54.63 | 217.0 | 2.85 | 53.23 | 131.71 | 67.83 | -14.82 | -3.6 | 43.25 | -2.92 | 33.9 | 28.60 | -23.18 | 50.21 | 1.23 | 48.19 | 207.5 | 0.91 | 33.82 | 506.67 | 39.07 | -9.37 | 32.13 | 28.60 | -23.18 | 50.21 | - | - | 0.00 |
| 20Q3 (4) | 41 | 0.0 | 0.0 | 1.68 | -19.62 | 0.0 | 1.25 | -20.89 | 0.0 | 4.10 | 70.12 | 0.0 | 1.86 | -27.63 | 0.0 | 79.63 | 3.83 | 0.0 | 44.55 | -8.62 | 0.0 | 37.23 | 4.23 | 0.0 | 0.83 | -33.6 | 0.0 | 0.68 | -20.0 | 0.0 | 43.11 | -8.26 | 0.0 | 37.23 | 4.23 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 41 | 0.0 | 0.0 | 2.09 | 533.33 | 0.0 | 1.58 | 777.78 | 0.0 | 2.41 | 630.3 | 0.0 | 2.57 | 99.22 | 0.0 | 76.69 | 2.09 | 0.0 | 48.75 | 162.52 | 0.0 | 35.72 | 117.8 | 0.0 | 1.25 | 420.83 | 0.0 | 0.85 | 553.85 | 0.0 | 46.99 | 127.89 | 0.0 | 35.72 | 117.8 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 41 | 5.13 | 0.0 | 0.33 | -15.38 | 0.0 | 0.18 | -43.75 | 0.0 | 0.33 | -83.5 | 0.0 | 1.29 | 4.88 | 0.0 | 75.12 | 6.77 | 0.0 | 18.57 | -42.51 | 0.0 | 16.40 | -13.87 | 0.0 | 0.24 | -40.0 | 0.0 | 0.13 | -13.33 | 0.0 | 20.62 | -30.27 | 0.0 | 16.40 | -13.87 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 39 | 0.0 | 0.0 | 0.39 | 0.0 | 0.0 | 0.32 | 0.0 | 0.0 | 2.00 | 0.0 | 0.0 | 1.23 | 0.0 | 0.0 | 70.36 | 0.0 | 0.0 | 32.30 | 0.0 | 0.0 | 19.04 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.15 | 0.0 | 0.0 | 29.57 | 0.0 | 0.0 | 19.04 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 0.15 | 3.94 | -11.2 | 1.67 | -11.2 | 0.6 | N/A | - | ||
| 2024/9 | 0.15 | -51.21 | 6.21 | 1.52 | -11.2 | 0.62 | 0.61 | - | ||
| 2024/8 | 0.3 | 69.44 | 59.61 | 1.37 | -12.73 | 0.58 | 0.65 | 主係畜產類產品出貨增加所致 | ||
| 2024/7 | 0.18 | 69.62 | 14.06 | 1.07 | -22.6 | 0.46 | 0.82 | - | ||
| 2024/6 | 0.1 | -42.24 | -45.52 | 0.89 | -27.26 | 0.43 | 1.18 | - | ||
| 2024/5 | 0.18 | 24.09 | 1.02 | 0.79 | -23.86 | 0.44 | 1.16 | - | ||
| 2024/4 | 0.15 | 29.63 | -14.86 | 0.6 | -29.09 | 0.36 | 1.43 | - | ||
| 2024/3 | 0.11 | 15.88 | -64.58 | 0.46 | -32.67 | 0.46 | 1.29 | 新冠PCR產品出貨減少所致 | ||
| 2024/2 | 0.1 | -61.04 | -26.74 | 0.35 | -4.82 | 0.53 | 1.11 | - | ||
| 2024/1 | 0.25 | 36.4 | 7.73 | 0.25 | 7.73 | 0.63 | 0.94 | - | ||
| 2023/12 | 0.18 | -5.66 | -23.76 | 2.25 | -69.93 | 0.55 | 1.22 | 新冠PCR產品出貨減少所致 | ||
| 2023/11 | 0.19 | 12.89 | -24.09 | 2.07 | -71.46 | 0.5 | 1.33 | 新冠PCR產品出貨減少所致 | ||
| 2023/10 | 0.17 | 24.33 | -51.99 | 1.88 | -73.19 | 0.5 | 1.35 | 新冠PCR產品出貨減少所致 | ||
| 2023/9 | 0.14 | -26.69 | -62.39 | 1.71 | -74.33 | 0.48 | 2.59 | 新冠PCR產品出貨減少所致 | ||
| 2023/8 | 0.19 | 21.09 | -46.71 | 1.57 | -75.02 | 0.54 | 2.33 | 新冠PCR產品出貨減少所致 | ||
| 2023/7 | 0.16 | -18.99 | -53.95 | 1.38 | -76.71 | 0.53 | 2.37 | 新冠PCR產品出貨減少所致 | ||
| 2023/6 | 0.19 | 7.1 | -40.33 | 1.22 | -78.09 | 0.54 | 2.82 | 新冠PCR產品出貨減少所致 | ||
| 2023/5 | 0.18 | 4.57 | -91.18 | 1.03 | -80.39 | 0.67 | 2.29 | 新冠PCR產品出貨減少所致 | ||
| 2023/4 | 0.17 | -46.06 | -80.44 | 0.85 | -73.61 | 0.62 | 2.46 | 新冠PCR產品出貨減少所致 | ||
| 2023/3 | 0.32 | 139.69 | -57.5 | 0.68 | -71.06 | 0.68 | 2.92 | 新冠PCR產品出貨減少所致 | ||
| 2023/2 | 0.13 | -42.71 | -62.1 | 0.36 | -77.37 | 0.6 | 3.3 | 新冠PCR產品出貨減少所致 | ||
| 2023/1 | 0.23 | -3.47 | -81.61 | 0.23 | -81.61 | 0.73 | 2.74 | 新冠PCR產品出貨減少及1月份工作天數較少所致 | ||
| 2022/12 | 0.24 | -6.07 | -75.95 | 7.5 | -25.89 | 0.85 | 2.77 | 新冠PCR產品出貨減少所致 | ||
| 2022/11 | 0.26 | -28.6 | -57.14 | 7.26 | -20.41 | 0.98 | 2.41 | 新冠PCR產品出貨減少所致 | ||
| 2022/10 | 0.36 | -2.59 | -42.64 | 7.01 | -17.85 | 1.08 | 2.19 | - | ||
| 2022/9 | 0.37 | 3.87 | -54.17 | 6.65 | -15.89 | 1.06 | 2.68 | 新冠PCR產品出貨減少所致 | ||
| 2022/8 | 0.35 | 4.63 | -66.69 | 6.28 | -11.58 | 1.01 | 2.8 | 新冠PCR產品出貨減少所致 | ||
| 2022/7 | 0.34 | 4.95 | -64.84 | 5.93 | -1.9 | 2.69 | 1.05 | 因應國內政策致客戶使用量下降，造成新冠PCR產品出貨減少所致 | ||
| 2022/6 | 0.32 | -84.18 | -70.69 | 5.59 | 9.99 | 3.23 | 0.83 | 因國內政府政策6月新冠PCR產品需求減少及代理商5月備貨所致 | ||
| 2022/5 | 2.03 | 132.07 | 97.89 | 5.27 | 32.24 | 3.66 | 0.74 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2022/4 | 0.88 | 17.2 | 39.16 | 3.23 | 9.4 | 1.97 | 1.36 | - | ||
| 2022/3 | 0.75 | 113.75 | -19.29 | 2.36 | 1.34 | 2.36 | 1.26 | - | ||
| 2022/2 | 0.35 | -72.21 | -52.86 | 1.61 | 15.01 | 2.61 | 1.14 | 係因代理商因應春節假期於1月底啟動備貨，致2月營收較同期減少 | ||
| 2022/1 | 1.26 | 26.23 | 91.74 | 1.26 | 91.74 | 2.85 | 1.04 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2021/12 | 1.0 | 67.44 | -3.78 | 10.12 | 18.09 | 2.22 | 1.21 | - | ||
| 2021/11 | 0.6 | -4.45 | -51.99 | 9.12 | 21.1 | 2.02 | 1.33 | 因去年同期銷售名台新冠病毒檢測設備所致 | ||
| 2021/10 | 0.62 | -22.16 | 9.29 | 8.53 | 35.51 | 2.49 | 1.08 | - | ||
| 2021/9 | 0.8 | -24.51 | 30.95 | 7.9 | 38.12 | 2.82 | 0.91 | - | ||
| 2021/8 | 1.06 | 10.44 | 45.65 | 7.1 | 38.98 | 3.12 | 0.82 | - | ||
| 2021/7 | 0.96 | -12.5 | 84.71 | 6.04 | 37.87 | 3.09 | 0.83 | 主係新冠病毒檢測產品銷售增加所致。 | ||
| 2021/6 | 1.1 | 6.82 | 54.19 | 5.08 | 31.56 | 2.76 | 0.97 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2021/5 | 1.03 | 63.2 | -2.22 | 3.98 | 26.45 | 2.58 | 1.03 | - | ||
| 2021/4 | 0.63 | -32.02 | -22.13 | 2.96 | 40.81 | 2.3 | 1.16 | - | ||
| 2021/3 | 0.93 | 24.83 | 77.97 | 2.33 | 80.29 | 2.33 | 1.14 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2021/2 | 0.74 | 13.03 | 204.82 | 1.4 | 81.86 | 2.44 | 1.09 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2021/1 | 0.66 | -36.66 | 24.9 | 0.66 | 24.9 | 2.93 | 0.91 | - | ||
| 2020/12 | 1.04 | -16.44 | 130.54 | 8.57 | 134.29 | 2.85 | 0.83 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2020/11 | 1.24 | 117.52 | 210.02 | 7.53 | 134.81 | 2.42 | 0.98 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2020/10 | 0.57 | -6.74 | 50.69 | 6.29 | 124.09 | 1.91 | 1.24 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2020/9 | 0.61 | -16.03 | 124.09 | 5.72 | 135.53 | 1.86 | 1.15 | 主係新冠病毒檢測產品銷售增加所致 | ||
| 2020/8 | 0.73 | 40.06 | 127.76 | 5.11 | 136.98 | 1.96 | 1.09 | 因新冠病毒檢測產品及水產、畜產檢測產品都持續增加出貨所致。 | ||
| 2020/7 | 0.52 | -26.95 | 154.19 | 4.38 | 138.58 | 2.28 | 0.94 | 主係因新冠病毒檢測產品持續出貨所致。 | ||
| 2020/6 | 0.71 | -32.26 | 143.25 | 3.86 | 136.63 | 2.57 | 0.65 | 主係新冠病毒檢測需求旺盛 | ||
| 2020/5 | 1.05 | 29.96 | 422.19 | 3.15 | 135.18 | 2.38 | 0.7 | 主係各國新冠病毒檢測需求旺盛及各產業營收成長所致。 | ||
| 2020/4 | 0.81 | 55.36 | 191.84 | 2.1 | 84.41 | 1.57 | 1.06 | 主係新冠肺炎及畜產相關產品需求旺盛所致。 | ||
| 2020/3 | 0.52 | 113.81 | 113.09 | 1.29 | 49.82 | 1.29 | 1.05 | 畜產及水產相關產品需求旺盛，另新冠病毒檢測產品包括設備及檢測試劑也開始出貨 | ||
| 2020/2 | 0.24 | -53.68 | -7.84 | 0.77 | 24.75 | 1.22 | 1.11 | - | ||
| 2020/1 | 0.53 | 16.91 | 49.19 | 0.53 | 49.19 | 1.38 | 0.98 | - | ||
| 2019/12 | 0.45 | 12.35 | 100.03 | 3.66 | 95.17 | 0.0 | N/A | 主係防疫需求增加，畜產產品出貨量增加所致。 | ||
| 2019/11 | 0.4 | 5.73 | 106.57 | 3.21 | 94.51 | 0.0 | N/A | 主係中東及中國地區出貨增加，及畜產、邊境防備相關產品銷貨量增加所致。 |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 57 | 23.91 | -2.89 | 0 | -3.11 | 0 | 2.25 | -70.0 | 12.23 | -81.28 | -101.70 | 0 | -75.56 | 0 | -2.29 | 0 | -2.18 | 0 | -1.66 | 0 |
| 2022 (9) | 46 | 9.52 | 4.67 | -47.23 | 3.33 | -51.32 | 7.5 | -25.89 | 65.34 | -11.48 | 32.18 | -32.48 | 29.00 | -20.79 | 2.41 | -50.0 | 2.72 | -42.0 | 2.21 | -41.38 |
| 2021 (8) | 42 | 2.44 | 8.85 | 39.81 | 6.84 | 42.8 | 10.12 | 18.09 | 73.81 | -0.45 | 47.66 | 14.93 | 36.61 | 18.98 | 4.82 | 35.77 | 4.69 | 38.35 | 3.77 | 46.69 |
| 2020 (7) | 41 | 5.13 | 6.33 | 226.29 | 4.79 | 228.08 | 8.57 | 134.15 | 74.14 | -10.21 | 41.47 | 35.52 | 30.77 | 20.2 | 3.55 | 216.96 | 3.39 | 222.86 | 2.57 | 233.77 |
| 2019 (6) | 39 | 14.71 | 1.94 | 148.72 | 1.46 | 595.24 | 3.66 | 95.72 | 82.57 | 3.61 | 30.60 | 404.12 | 25.60 | 61.31 | 1.12 | 918.18 | 1.05 | 262.07 | 0.77 | 165.52 |
| 2018 (5) | 34 | 0.0 | 0.78 | 0 | 0.21 | 0 | 1.87 | 20.65 | 79.69 | -1.25 | 6.07 | 0 | 15.87 | 0 | 0.11 | 0 | 0.29 | 0 | 0.29 | 0 |
| 2017 (4) | 34 | 0.0 | -1.40 | 0 | -0.42 | 0 | 1.55 | 3.33 | 80.70 | -0.05 | -13.78 | 0 | -30.97 | 0 | -0.21 | 0 | -0.45 | 0 | -0.48 | 0 |
| 2016 (3) | 34 | 0.0 | -1.13 | 0 | -0.47 | 0 | 1.5 | 0.67 | 80.74 | 2.32 | -17.75 | 0 | -25.73 | 0 | -0.27 | 0 | -0.39 | 0 | -0.39 | 0 |
| 2015 (2) | 34 | 6.25 | -0.72 | 0 | -0.47 | 0 | 1.49 | 11.19 | 78.91 | -1.65 | -18.07 | 0 | -16.64 | 0 | -0.27 | 0 | -0.25 | 0 | -0.25 | 0 |
| 2014 (1) | 32 | 6.67 | -0.96 | 0 | -0.58 | 0 | 1.34 | 39.58 | 80.23 | 0 | -31.62 | 0 | -22.77 | 0 | -0.42 | 0 | -0.39 | 0 | -0.3 | 0 |
